EE200400042A - 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena - Google Patents

8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena

Info

Publication number
EE200400042A
EE200400042A EEP200400042A EEP200400042A EE200400042A EE 200400042 A EE200400042 A EE 200400042A EE P200400042 A EEP200400042 A EE P200400042A EE P200400042 A EEP200400042 A EE P200400042A EE 200400042 A EE200400042 A EE 200400042A
Authority
EE
Estonia
Prior art keywords
alanyl
heterocyclic compounds
ligase inhibitors
alanine ligase
alanine
Prior art date
Application number
EEP200400042A
Other languages
English (en)
Estonian (et)
Inventor
T. Moe Scott
J. Ala Paul
Perola Emanuele
H. Faerman Carlos
J. Clement Jacob
A. Ali Janid
M. Will Paul
A. Marchese Salvatore
S. Magee Andrew
V. Gazzaniga John
Farady Christopher
A. Navia Manuel
R. Connelly Patrick
Original Assignee
Essential Therapeutics, Inc.
Pliva D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essential Therapeutics, Inc., Pliva D.D. filed Critical Essential Therapeutics, Inc.
Publication of EE200400042A publication Critical patent/EE200400042A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200400042A 2001-06-28 2002-06-28 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena EE200400042A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30168501P 2001-06-28 2001-06-28
PCT/US2002/020567 WO2003001887A2 (en) 2001-06-28 2002-06-28 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors

Publications (1)

Publication Number Publication Date
EE200400042A true EE200400042A (et) 2004-10-15

Family

ID=23164426

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200400042A EE200400042A (et) 2001-06-28 2002-06-28 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena
EEP200400043A EE200400043A (et) 2001-06-28 2002-06-28 Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP200400043A EE200400043A (et) 2001-06-28 2002-06-28 Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine

Country Status (16)

Country Link
US (3) US20030176436A1 (hu)
EP (2) EP1432713A4 (hu)
CN (2) CN1547472A (hu)
BG (1) BG108548A (hu)
BR (1) BR0211310A (hu)
CA (2) CA2451800A1 (hu)
CZ (2) CZ200442A3 (hu)
EA (1) EA200400094A1 (hu)
EE (2) EE200400042A (hu)
HU (2) HUP0700061A2 (hu)
IL (2) IL159538A0 (hu)
MX (1) MXPA04000159A (hu)
PL (2) PL374259A1 (hu)
SK (1) SK302004A3 (hu)
WO (2) WO2003002064A2 (hu)
YU (2) YU102503A (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217703D0 (en) * 2002-07-31 2002-09-11 Univ Liverpool Pharmaceutical composition
WO2006050843A1 (en) * 2004-11-09 2006-05-18 F. Hoffmann-La Roche Ag Aminoquinazolines compounds
MX2008000885A (es) * 2005-07-21 2008-03-18 Hoffmann La Roche Compuestos de pirido[2,3-d]pirimidin-2,4-diamina como inhibidores de la proteina tirosina fosfatasa 1b.
GB0608822D0 (en) * 2006-05-04 2006-06-14 Chroma Therapeutics Ltd Inhibitors of DHFR
SI22338A (sl) * 2006-08-18 2008-02-29 Univerza V Ljubljani, Fakulteta Za Farmacijo Diazendikarboksamidi kot inhibitorji d-alanil-d-alanin ligaze
TW200831528A (en) 2006-11-30 2008-08-01 Astrazeneca Ab Compounds
CN101084901B (zh) * 2007-06-22 2011-12-21 复旦大学 一种葡萄球菌抑制剂
CN101983191B (zh) * 2008-02-01 2013-11-20 武田药品工业株式会社 作为hsp90抑制剂的肟衍生物
DE112010001212T5 (de) * 2009-03-20 2012-07-05 The Board Of Regents Of The University Of Texas System Verfahren, urn einem medizinischen Gerät antimikrobielle Aktivität zu verleihen
NZ597911A (en) * 2009-08-31 2014-06-27 Dow Agrosciences Llc Pteridines and their use as agrochemicals
SI3321265T1 (sl) 2015-03-04 2020-07-31 Gilead Sciences, Inc. Spojine 4,6-diamino-pirido(3,2-d)pirimidina in njihova uporaba kot modulatorji toličnih receptorjev
CN106316966A (zh) * 2015-06-15 2017-01-11 董运勤 医药中间体n-(2-吡嗪甲基)苄胺磷酸盐化合物制备方法
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
KR20200012823A (ko) 2017-02-01 2020-02-05 예일 유니버시티 이뇨제 내성의 치료
EP3735421A4 (en) 2018-01-05 2021-09-22 Corvidia Therapeutics, Inc. METHOD OF TREATMENT OF IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNSUPPRESSION
TW202045001A (zh) * 2019-02-01 2020-12-16 美商富曼西公司 作為除草劑的經取代吡啶類及嘧啶類化合物
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
GB2626567A (en) * 2023-01-26 2024-07-31 De Montfort Univ Quinazoline derivatives for use as a medicament

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) * 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
US3134778A (en) * 1963-08-20 1964-05-26 Smith Kline French Lab 2,5,7-triamino-4-phenyl (or thienyl)-pyrimido[4,5-d]pyrimidines
RO56210A2 (hu) 1970-12-28 1974-08-01
US4079056A (en) * 1975-03-31 1978-03-14 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making pteridine compounds
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3445298A1 (de) 1984-12-12 1986-06-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
WO1992017478A1 (en) 1991-04-08 1992-10-15 Duquesne University Of The Holy Ghost 5-ALKYL-6-[[AMINO]METHYL]PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF PREPARING AND USING THESE DERIVATIVES
US5547954A (en) * 1994-05-26 1996-08-20 Fmc Corporation 2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
DE59610771D1 (de) * 1995-02-27 2003-11-20 Hoffmann La Roche Dioxopyrrolo-pyrrolderivate
WO1999050264A1 (fr) * 1998-03-30 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Derives de quinazoline
JP2000239277A (ja) * 1999-02-19 2000-09-05 Kyowa Hakko Kogyo Co Ltd イミダゾキナゾリン誘導体
GB0219893D0 (en) 2002-08-27 2002-10-02 Melacure Therapeutics Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
BR0211310A (pt) 2006-10-31
EP1411949A2 (en) 2004-04-28
CN1543465A (zh) 2004-11-03
HUP0700061A2 (en) 2007-05-02
WO2003002064A3 (en) 2003-10-23
CZ200443A3 (cs) 2004-08-18
YU102503A (sh) 2006-08-17
YU102303A (sh) 2006-08-17
WO2003001887A3 (en) 2003-08-21
EP1432713A4 (en) 2005-05-11
US20080090847A1 (en) 2008-04-17
US7345048B2 (en) 2008-03-18
BG108548A (bg) 2005-05-31
CA2451800A1 (en) 2003-01-09
WO2003001887A2 (en) 2003-01-09
PL374259A1 (en) 2005-10-03
CA2451840A1 (en) 2003-01-09
EE200400043A (et) 2004-10-15
SK302004A3 (sk) 2005-07-01
US20030181470A1 (en) 2003-09-25
US20030176436A1 (en) 2003-09-18
CZ200442A3 (cs) 2004-10-13
WO2003002064A2 (en) 2003-01-09
CN1547472A (zh) 2004-11-17
EP1432713A2 (en) 2004-06-30
IL159540A0 (en) 2004-06-01
EA200400094A1 (ru) 2005-08-25
MXPA04000159A (es) 2005-01-07
HUP0700040A2 (en) 2007-05-29
EP1411949A4 (en) 2004-11-24
IL159538A0 (en) 2004-06-01
PL374589A1 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
EE200400042A (et) 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena
EE200300325A (et) Asendatud amiini derivaadid ning nende kasutamismeetodid
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
HK1068874A1 (en) Heterocyclic compounds and methods of use
ATE269701T1 (de) Gyrase-inhibitoren und ihre verwendung
ATE253576T1 (de) 8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
EE200300459A (et) Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena
IS7138A (is) Alkýn-arýl fosfódíesterasa-4 hindrar
DE60207627D1 (de) Überzug und Überzugszusammensetzung
ATE407131T1 (de) Substituierte bipiperidine -zwischenverbindungen und deren derivate
HK1074176A1 (en) Quinoline derivatives as neuropeptide y antagonists
EE200300134A (et) Uued tiadiasoolid ja oksadiasoolid ning nende kasutamine fosfodiesteraas-7 inhibiitoritena
DE60219068D1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
DK1442050T3 (da) Lineære basiske forbindelser med NK-2-antagonistaktivitet samt formuleringer deraf
PL367639A1 (en) Novel heterocyclic compound and medicinal use thereof
DE60101245D1 (de) Beschichtungszusammensetzung und ihre Verwendung
DE60225446D1 (de) Flammgeschützte zusammensetzung und artikel
PL369736A1 (en) New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
DE60230536D1 (de) Zusammensetzung und verfahren
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
ATE347544T1 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung
GB0021315D0 (en) Heterocyclic compounds and intermediates thereof
DE50209548D1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl-but-2-enylaminverbindungen